Related Experiment Video
Updated: Nov 18, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.1K
Heart failure in advanced chronic kidney disease: treatment rationale
1Department of Internal Medicine I (Cardiology), University Hospital, RWTH Aachen University, Pauwelsstraße 30, 52074, Aachen, Germany. nmarx@ukaachen.de.
Herz
|February 10, 2021
Insights
Patients with chronic kidney disease (CKD) face higher heart failure risks and poorer outcomes. This article reviews standard heart failure treatments and their specific considerations for CKD patients.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Patients with chronic kidney disease (CKD) have a significantly elevated risk of developing heart failure.
- The co-existence of heart failure and CKD is associated with a poorer prognosis and increased mortality.
- Understanding the interplay between these conditions is crucial for effective patient management.
Purpose of the Study:
- To provide an overview of current standard medical therapies for heart failure.
- To discuss the specific adaptations and considerations for treating heart failure in patients with CKD.
- To highlight the challenges and nuances in managing comorbid CKD and heart failure.
Main Methods:
- Literature review of current guidelines and clinical studies on heart failure treatment.
- Analysis of therapeutic strategies focusing on efficacy and safety in CKD populations.
- Synthesis of evidence regarding drug selection, dosage adjustments, and monitoring in CKD patients with heart failure.
Main Results:
- Standard heart failure therapies require careful modification in CKD patients due to altered pharmacokinetics and pharmacodynamics.
- Certain medications commonly used in heart failure may be less effective or pose higher risks in individuals with impaired kidney function.
- Individualized treatment approaches are necessary, balancing cardiorenal benefits and risks.
Conclusions:
- Effective management of heart failure in CKD patients necessitates a multidisciplinary approach.
- Treatment strategies must be tailored to the individual patient's degree of kidney dysfunction and cardiac status.
- Further research is needed to optimize heart failure therapies specifically for the CKD population to improve outcomes.
Abstract:
Patients with chronic kidney disease (CKD) exhibit an increased risk to develop heart failure and the presence of heart failure in patients with CKD leads to a worse prognosis. The following overview article summarizes the current standard of medical heart failure therapy and discusses the treatment characteristics in patients with CKD.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
610
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
610
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
666
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
666
01:18Chronic Kidney Disease IV: Nursing Management
142
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
142
01:30Heart Failure V: Medical Management
89
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
89
01:22Heart Failure VI: Adjunct Therapies
107
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
107
01:28Chronic Kidney Disease III: Interprofessional Care
202
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
202